Skip to main content
. 2021 Aug 10;6(5):958–967. doi: 10.1002/lio2.633

FIGURE 4.

FIGURE 4

The schema of hybrid gene therapy based on a combination with cochlear implants. In patients with high‐frequency hearing loss, cochlear implants (CIs) improve hearing ability, while the natural course of low‐frequency hearing loss is observed (upper). Residual hearing can be preserved by performing cochlear gene therapy through CIs (lower)